Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
This study has been completed.
Study NCT00222911   Information provided by University of Pittsburgh
First Received: September 20, 2005   Last Updated: May 19, 2008   History of Changes

September 20, 2005
May 19, 2008
August 2005
 
  • the range of pain-free passive ankle joint dorsiflexion at baseline and 6 weeks
  • plantar heel tenderness at baseline and 6 weeks
  • plantar heel pain at baseline and 6 weeks
  • disability imposed by the heel pain/plantar fasciitis at baseline and 6 weeks
  • -the range of pain-free passive ankle joint dorsiflexion at baseline and 6 weeks
  • -plantar heel tenderness at baseline and 6 weeks
  • -plantar heel pain at baseline and 6 weeks
  • -disability imposed by the heel pain/plantar fasciitis at baseline and 6 weeks
Complete list of historical versions of study NCT00222911 on ClinicalTrials.gov Archive Site
medial longitudinal arch height at baseline
-medial longitudinal arch height at baseline
 
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study

The overall purpose of this study is to examine the combined effect of both dorsiflexion night splints and medial arch supports and compare it to the effect of these interventions each by itself in the treatment of plantar fasciitis.

Plantar fasciitis is an overuse injury causing inflammation at the origin of the plantar fascia and is characterized by plantar heel pain that is provoked by taking the first few steps in the morning and by prolonged standing. It is the most common clinical problem that causes inferomedial heel pain in adults. It is estimated that more than two million people receive treatment for plantar fasciitis in the United States each year. Despite its familiarity to physicians, the exact etiology of plantar fasciitis remains obscure. The variety of treatments noted in the literature attests to the uncertainty of the etiology and pathogenesis of plantar fasciitis. It has been suggested that the success of conservative care for the treatment of patients with plantar fasciitis requires a combination of treatment modalities. Although many authors have stated that mechanical therapy should be considered a cornerstone of any effective treatment plan, some debate remains regarding the most effective form of mechanical treatment. The literature provides evidence to support the use of dorsiflexion night splints and medial arch supports in the treatment of plantar fasciitis. A night splint is used to address early morning pain by preventing contracture of the plantar fascia and Achilles tendon overnight. An arch support, on the other hand, addresses the end of the day pain by preventing overstretch of the plantar fascia during prolonged weight bearing. Therefore, both night splints and arch supports may be necessary to treat plantar fasciitis as they complement each other by both controlling nocturnal contracture of the plantar fascia and Achilles tendon and reducing stresses imposed on the plantar fascia during the day, respectively. This prospective randomized study, to the best of our awareness, is the first that addresses this problem by examining the combined effect of these treatment modalities and comparing it to the effect of a night splint or arch support each by itself. We hypothesize that the night splint and arch support together will be more effective in the treatment of plantar fasciitis than night splint or arch support alone in terms of increasing the range of pain-free passive ankle dorsiflexion, relieving heel tenderness and pain, and reducing disability imposed by the heel pain/plantar fasciitis. A secondary hypothesis of this study is that those with limited passive dorsiflexion of the ankle will benefit from a night splint more than those with normal passive dorsiflexion of the ankle and those with a low medial longitudinal arch will benefit from an arch support more than those with a normal medial longitudinal arch in terms of the previously mentioned outcomes. The range of motion will be measured with a goniometer; heel tenderness will be measured with a pressure algometer; and pain and disability will be measured by the Foot Function Index.

Phase IV
Interventional
Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Plantar Fasciitis
  • Device: dorsiflexion night splint
  • Device: medial arch support
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
75
November 2006
 

Inclusion Criteria:

  • plantar heel pain
  • pain is provoked by taking the first few steps in the morning, by standing after prolonged sitting, and/or by prolonged standing
  • tenderness localized to the origin of the plantar fascia on the medial calcaneal tubercle

Exclusion Criteria:

  • previous foot surgery
  • foot trauma within the previous three months
  • tarsal tunnel syndrome
  • loss of plantar foot sensation
  • foot pathology other than plantar fasciitis including tendonitis, bursitis, or calcaneus fracture
  • generalized inflammatory disorders associated with the diagnosis of plantar fasciitis including rheumatoid arthritis, ankylosing spondylitis, Reiter's disease, gout, or lupus
  • previous treatment of plantar fasciitis with dorsiflexion night splints and/or medial arch supports
  • inability or unwillingness to discontinue current treatment modalities that are used for the purpose of plantar fasciitis
  • participation in a worker's compensation program
  • age of less than 18 years
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00222911
 
0506173
University of Pittsburgh
Saudi Arabian Cultural Mission
Principal Investigator: Ahmad H Alghadir, MS, PT University of Pittsburgh
Study Chair: James Irrgang, PhD, PT University of Pittsburgh
Study Director: Anthony Delitto, PhD, PT University of Pittsburgh
Study Director: Dane Wukich, MD University of Pittsburgh
Study Director: Ray Burdett, PhD, PT University of Pittsburgh
University of Pittsburgh
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP